[go: up one dir, main page]

EE05678B1 - Tahke koostis, mis koosneb peamiselt kollageenkandjast, tahkest fibrinogeenist ja tahkest trombiinist, ning selle kasutamine - Google Patents

Tahke koostis, mis koosneb peamiselt kollageenkandjast, tahkest fibrinogeenist ja tahkest trombiinist, ning selle kasutamine

Info

Publication number
EE05678B1
EE05678B1 EEP200300348A EEP200300348A EE05678B1 EE 05678 B1 EE05678 B1 EE 05678B1 EE P200300348 A EEP200300348 A EE P200300348A EE P200300348 A EEP200300348 A EE P200300348A EE 05678 B1 EE05678 B1 EE 05678B1
Authority
EE
Estonia
Prior art keywords
solid
composition consisting
thrombin
fibrinogen
collagen carrier
Prior art date
Application number
EEP200300348A
Other languages
English (en)
Inventor
Stimmeder Dagmar
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of EE200300348A publication Critical patent/EE200300348A/et
Publication of EE05678B1 publication Critical patent/EE05678B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/36—Surgical swabs, e.g. for absorbency or packing body cavities during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/044—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/046—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00—Macromolecular products derived from proteins
    • C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00463—Plasters use haemostatic
    • A61F2013/00472—Plasters use haemostatic with chemical means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Medicinal Preparation (AREA)
EEP200300348A 2001-01-25 2002-01-25 Tahke koostis, mis koosneb peamiselt kollageenkandjast, tahkest fibrinogeenist ja tahkest trombiinist, ning selle kasutamine EE05678B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200100135 2001-01-25
DKPA200100235 2001-02-13
PCT/IB2002/001453 WO2002058749A2 (en) 2001-01-25 2002-01-25 Carrier with solid fibrinogen and solid thrombin

Publications (2)

Publication Number Publication Date
EE200300348A EE200300348A (et) 2003-10-15
EE05678B1 true EE05678B1 (et) 2013-10-15

Family

ID=26068956

Family Applications (3)

Application Number Title Priority Date Filing Date
EEP200300341A EE05685B1 (et) 2001-01-25 2002-01-25 Fibrinogeeni, trombiini ja alkoholi sisaldav suspensioon ning meetod kandja katmiseks selle suspensiooniga
EEP200300349A EE05587B1 (et) 2001-01-25 2002-01-25 Meetod kollageenk„sna valmistamiseks
EEP200300348A EE05678B1 (et) 2001-01-25 2002-01-25 Tahke koostis, mis koosneb peamiselt kollageenkandjast, tahkest fibrinogeenist ja tahkest trombiinist, ning selle kasutamine

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EEP200300341A EE05685B1 (et) 2001-01-25 2002-01-25 Fibrinogeeni, trombiini ja alkoholi sisaldav suspensioon ning meetod kandja katmiseks selle suspensiooniga
EEP200300349A EE05587B1 (et) 2001-01-25 2002-01-25 Meetod kollageenk„sna valmistamiseks

Country Status (36)

Country Link
EP (4) EP1547626A3 (et)
JP (4) JP4104462B2 (et)
KR (2) KR100847417B1 (et)
CN (3) CN1290907C (et)
AR (3) AR032800A1 (et)
AT (2) ATE310044T1 (et)
AU (3) AU2002307809B2 (et)
BG (3) BG66420B1 (et)
BR (3) BRPI0206705B8 (et)
CA (3) CA2435425C (et)
CL (1) CL2015003111A1 (et)
CR (1) CR7034A (et)
CZ (3) CZ304357B6 (et)
DE (2) DE60207389T2 (et)
DK (2) DK1368419T3 (et)
EA (4) EA006540B1 (et)
EE (3) EE05685B1 (et)
EG (2) EG24589A (et)
ES (2) ES2238569T3 (et)
HR (1) HRP20030648B1 (et)
HU (3) HU227987B1 (et)
IL (6) IL157097A0 (et)
IS (1) IS6885A (et)
ME (1) ME00587A (et)
MX (3) MXPA03006688A (et)
NO (3) NO20033297L (et)
NZ (3) NZ527167A (et)
PL (3) PL205181B1 (et)
PT (1) PT1343542E (et)
RS (1) RS50866B (et)
SI (2) SI1368419T1 (et)
SK (3) SK287874B6 (et)
TW (2) TWI237573B (et)
UA (1) UA73028C2 (et)
UY (1) UY27136A1 (et)
WO (3) WO2002058750A2 (et)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131933A1 (en) * 1996-01-16 2002-09-19 Yves Delmotte Biopolymer membrane and methods for its preparation
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US7252837B2 (en) 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
WO2004041254A1 (en) * 2002-11-04 2004-05-21 Nycomed Danmark Aps Coating of a particulate material with an organic solvent-based coating composition
EP1588722A4 (en) 2003-01-20 2011-03-02 Chemo Sero Therapeut Res Inst HEMOSTATIC MATERIALS
AU2004226578A1 (en) 2003-04-04 2004-10-14 Tissuemed Limited Tissue-adhesive formulations
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US7186684B2 (en) * 2003-08-07 2007-03-06 Ethicon, Inc. Hemostatic device containing a protein precipitate
BRPI0514106A (pt) 2004-08-03 2008-05-27 Tissuemed Ltd materiais adesivos a tecidos
US20060080815A1 (en) 2004-10-20 2006-04-20 Pendharkar Sanyog M Method for making a reinforced absorbable multilayered fabric for use in medical devices
KR20070095870A (ko) 2004-10-20 2007-10-01 에디컨인코포레이티드 흡수성 지혈제
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
KR20060040329A (ko) * 2004-11-05 2006-05-10 나건 내시경을 통하여 도포 가능한 체내 지혈제 및 그 도포 방법
ES2427565T3 (es) 2005-04-25 2013-10-31 Massachusetts Institute Of Technology Péptidos autoensambladores para promover la hemostasia
JP4864348B2 (ja) * 2005-05-27 2012-02-01 川澄化学工業株式会社 神経再生チューブ
KR20080102152A (ko) 2006-02-03 2008-11-24 티슈메드 리미티드 조직-접착 물질
US9579415B2 (en) 2006-02-14 2017-02-28 Cook Incorporated Joining and/or sealing tissues through photo-activated cross-linking of matrix proteins
KR20090015935A (ko) 2006-04-25 2009-02-12 메사추세츠 인스티튜트 오브 테크놀로지 오염물, 체액 또는 다른 실재물의 이동 및/또는 다른 생리학적 상태에 영향을 주기 위한 조성물 및 방법
US8703122B2 (en) 2006-05-31 2014-04-22 Baxter International Inc. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
WO2008019129A2 (en) * 2006-08-04 2008-02-14 Stb Lifesaving Technologies, Inc. Solid dressing for treating wounded tissue
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
TWI440664B (zh) * 2007-02-05 2014-06-11 Asahi Kasei E Materials Corp Hydrogen storage alloy and resin composition
CN101053679B (zh) * 2007-04-17 2010-05-26 浙江大学 一种纤维蛋白凝胶填充的聚合物多孔支架的制备方法
DE102007037053A1 (de) 2007-07-24 2009-01-29 Aesculap Ag Hämostyptikum für die minimal-invasive Operation
DE102007037056A1 (de) 2007-07-24 2009-01-29 Aesculap Ag Hämostyptikum
DE102007045066A1 (de) 2007-09-20 2009-04-02 Mike Ehrlich Material zur Blutstillung enthaltend synthetische Peptide oder Polysaccharide
DE102007000574A1 (de) 2007-10-25 2009-04-30 FILK Forschungsinstitut für Leder- und Kunstbahnen gGmbH Biologisch resorbierbares Schwammmaterial und Verfahren zu dessen Herstellung
US8790698B2 (en) 2007-10-30 2014-07-29 Baxter International Inc. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
CN101214391B (zh) * 2007-12-27 2010-05-19 广州倍绣生物技术有限公司 一种高效生物胶封闭剂及其应用
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
WO2010002435A2 (en) * 2008-07-03 2010-01-07 Kulinets Irina B Hemostatic pouch and method to stabilize hemostatic components
EP4183425A1 (en) 2008-10-06 2023-05-24 3-D Matrix Ltd. Tissue plug
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
EP2442835B1 (en) 2009-06-16 2014-12-10 Baxter International Inc Hemostatic sponge
EP2477617B1 (en) 2009-09-18 2018-01-31 Bioinspire Technologies Inc. Free-standing biodegradable patch
US9271925B2 (en) 2013-03-11 2016-03-01 Bioinspire Technologies, Inc. Multi-layer biodegradable device having adjustable drug release profile
US9439941B2 (en) 2009-12-14 2016-09-13 The University Of Hong Kong Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
CN102753203A (zh) 2009-12-16 2012-10-24 巴克斯特国际公司 止血海绵
BR112012018970B1 (pt) * 2010-01-28 2018-10-30 Omrix Biopharmaceuticals Ltd produto compreendendo fibrinogênio, thrombina e formulação de selante de fibrina líquida, método para preparação do mesmo e kit
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
CN102917691A (zh) 2010-06-01 2013-02-06 巴克斯特国际公司 用于生产干燥、稳定的止血组合物的方法
EP2575775B1 (en) 2010-06-01 2018-04-04 Baxter International Inc. Process for making dry and stable hemostatic compositions
US8940335B2 (en) 2010-06-01 2015-01-27 Baxter International Inc. Process for making dry and stable hemostatic compositions
US20130183366A1 (en) 2010-07-20 2013-07-18 The Chemo-Sero-Therapeutic Research Institute Sheet preparation for tissue adhesion
ME02830B (me) * 2011-05-24 2018-01-20 Takeda As Umotani kolagenski nosač
RU2013155713A (ru) * 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
CN102357259A (zh) 2011-07-28 2012-02-22 王珊珊 一种生物蛋白海绵及其制备方法
US20130041406A1 (en) * 2011-08-10 2013-02-14 Brian W. Bear Surgical staple with localized adjunct coating
EP2556842A1 (en) 2011-08-11 2013-02-13 Bioftalmik, S.L. Composition in the form of film comprising fibrinogen and a fibrinogen activator and the applications thereof
JP6195569B2 (ja) 2011-10-11 2017-09-13 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 止血組成物
CA2851338C (en) 2011-10-11 2019-11-05 Baxter International Inc. Hemostatic compositions
PT2771027E (pt) 2011-10-27 2015-11-26 Baxter Healthcare Sa Composições hemostáticas
JP6241624B2 (ja) 2012-03-06 2017-12-06 フェロサン メディカル デバイシーズ エイ／エス 止血ペーストを収容する加圧容器
JP5844894B2 (ja) * 2012-05-14 2016-01-20 帝人株式会社 シート成形体および止血材
PL2854737T3 (pl) * 2012-05-24 2017-04-28 Takeda As Opakowanie
JP6242873B2 (ja) 2012-05-24 2017-12-06 タケダ エイエスＴａｋｅｄａ ＡＳ コイル状コラーゲンキャリアを提供する装置およびプロセス
JP6394916B2 (ja) 2012-06-12 2018-09-26 フェロサン メディカル デバイシーズ エイ／エス 乾燥止血組成物
WO2014008400A2 (en) 2012-07-06 2014-01-09 3-D Matrix, Inc. Fill-finish process for peptide solutions
DE102013004420A1 (de) 2012-08-20 2014-02-20 Alexander Kopp Stützkörper und Verfahren zu seiner Herstellung
US9168325B2 (en) * 2012-12-07 2015-10-27 Baxter International Inc. Hemostatic foam
KR101401944B1 (ko) * 2012-12-11 2014-05-30 세원셀론텍(주) 콜라겐과 피브린이 혼합된 조직 실란트 및 그 제조방법
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US10765774B2 (en) 2013-07-09 2020-09-08 Ethicon, Inc. Hemostatic pad assembly kit and method
CN105828844B (zh) 2013-12-11 2019-09-27 弗罗桑医疗设备公司 包含挤出增强剂的干组合物
US10369237B2 (en) 2014-03-10 2019-08-06 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
RU2016139369A (ru) 2014-03-10 2018-04-10 3-Д Матрикс, Лтд. Композиции самоорганизующихся пептидов
ES2712608T3 (es) 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares
US11046818B2 (en) 2014-10-13 2021-06-29 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
CN107206165B (zh) 2014-12-24 2020-10-23 弗罗桑医疗设备公司 用于保持并混合第一和第二物质的注射器
AU2016290433B2 (en) 2015-07-03 2018-05-24 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
CN106267328B (zh) * 2016-09-20 2019-04-12 安徽思维特生物科技有限公司 一种聚己内酯-胎牛皮胶原纤维复合止血凝胶的制备方法
CN106730031A (zh) * 2016-12-30 2017-05-31 清华大学 一种用于脊髓损伤修复的仿生纤维蛋白水凝胶束及其制备方法
WO2019116092A1 (en) 2017-12-15 2019-06-20 3-D Matrix, Ltd. Surfactant peptide nanostructures and uses in drug delivery
EP3790600B1 (en) 2018-05-09 2023-12-27 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
RU2679616C1 (ru) * 2018-07-02 2019-02-12 Государственное бюджетное учреждение здравоохранения города Москвы Научно-исследовательский институт скорой помощи имени Н.В. Склифосовского Департамента здравоохранения г. Москвы Способ приготовления тромбофибринового сгустка, обладающего ростстимулирующими свойствами
US20220016311A1 (en) * 2018-12-14 2022-01-20 Bmg Incorporated Two-reactant sheet-shaped adhesive/reinforcement for tissues
MX2021011420A (es) 2019-03-20 2021-10-13 Astellas Pharma Inc Lamina hemostatica portadora de trombina.
US20210228765A1 (en) * 2020-01-28 2021-07-29 Becton, Dickinson And Company Self-activating catheter insertion site dressing
CN112225937B (zh) * 2020-10-14 2022-11-01 中山大学 一种温敏型大孔生物水凝胶及其制备方法和应用
CN113117158B (zh) * 2021-03-10 2022-07-26 复旦大学 表面变性蛋白生物功能化修饰的材料及其制备方法和应用
CN114177346B (zh) * 2021-12-24 2023-05-26 中国人民解放军军事科学院军事医学研究院 一种止血组合物及止血贴与其应用
CN114246974B (zh) * 2021-12-24 2023-11-03 中国人民解放军军事科学院军事医学研究院 一种止血贴的制备方法
WO2025023336A1 (ko) * 2023-07-21 2025-01-30 주식회사 덴하우스 지혈용 스펀지
PL248607B1 (pl) * 2023-12-18 2026-01-05 Politechnika Łódzka Sposób wytwarzania wielowarstwowej kompozytowej pianki

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1596789A (et) * 1968-11-27 1970-06-22
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
BR8102435A (pt) * 1981-04-15 1982-11-30 Campos Vidal Benedicto Colageno i microfibrilar e microcristalino para aplicacao em medicina e farmacia
DE3214337C2 (de) * 1982-04-19 1984-04-26 Serapharm - Michael Stroetmann, 4400 Münster Resorbierbares Flachmaterial zum Abdichten und Heilen von Wunden und Verfahren zu dessen Herstellung
US4626286A (en) 1983-10-31 1986-12-02 Schmid Laboratories, Inc. Collagen gel and the process of making said gel
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
FR2668936B1 (fr) * 1990-11-09 1993-01-15 Eberlin Jean Luc Greffon a base de collagene et de colle de fibrine pour la reconstruction osteo-cartilagineuse et son procede de preparation.
BR9205864A (pt) * 1991-04-08 1994-06-28 Sumitomo Pharma Formulações sólidas porosas contendo substâncias proteináceas fisiologicamente ativas.
AT410754B (de) * 1993-03-31 2003-07-25 Nycomed Austria Gmbh Vorrichtung zum gleichmässigen auftragen einer suspension auf einen kollagenträger
US6177126B1 (en) * 1993-03-31 2001-01-23 Nycomed Arzneimittel Gmbh Process for the production of a material for sealing and healing wounds
JPH0759812A (ja) * 1993-08-27 1995-03-07 Koken Co Ltd 創傷カバ−材及びその製造方法
EP0778884A1 (en) * 1994-09-02 1997-06-18 New York Blood Center, Inc. Production and secretion of recombinant fibrinogen by yeast
CA2245585A1 (en) * 1996-02-06 1997-08-14 David P. Kosow Composition for sealing wounds
CA2251475C (en) * 1996-04-04 2006-09-05 Immuno Aktiengesellschaft Hemostatic sponge based on collagen
EP1073485B1 (en) * 1998-05-01 2003-03-19 ZymoGenetics, Inc. Fully recombinant tissue sealant compositions
EP0998311B1 (en) * 1998-05-19 2003-11-26 American National Red Cross Hemostatic sandwich bandage comprising a thrombin layer between two fibrinogen layers
MXPA01001510A (es) * 1998-08-10 2003-08-20 Fibrogen Inc Composiciones hemostaticas de colageno tipo i y tipo iii para usarse como sellador vascular y vendaje para heridas.
ES2183606T5 (es) * 1998-12-23 2008-05-16 Csl Behring Gmbh Granulado de adhesivo de fibrina y procedimiento para su preparacion.
DE19922078A1 (de) * 1999-05-15 2000-11-23 Weitzel Kage Doris Gewebekonstrukt für die Transplantationschirurgie

Also Published As

Publication number Publication date
IL157095A (en) 2009-06-15
IL157097A (en) 2009-12-24
CN1246047C (zh) 2006-03-22
IS6885A (is) 2003-07-24
NZ527166A (en) 2005-03-24
BRPI0206705B8 (pt) 2021-07-27
EP1368419B1 (en) 2005-11-16
PL366932A1 (en) 2005-02-07
NO327386B1 (no) 2009-06-22
PL363275A1 (en) 2004-11-15
EA200300821A1 (ru) 2004-04-29
CN1264578C (zh) 2006-07-19
SK287874B6 (sk) 2012-02-03
WO2002058750A8 (en) 2004-03-11
BRPI0206708B8 (pt) 2021-06-22
DE60203364T2 (de) 2005-09-01
NZ527167A (en) 2005-02-25
BG108123A (bg) 2004-09-30
TWI237573B (en) 2005-08-11
ES2238569T3 (es) 2005-09-01
AR032800A1 (es) 2003-11-26
NZ527165A (en) 2005-02-25
NO332462B1 (no) 2012-09-24
EA006540B1 (ru) 2006-02-24
TWI255726B (en) 2006-06-01
JP2005502733A (ja) 2005-01-27
HU227987B1 (hu) 2012-07-30
CZ20032198A3 (cs) 2003-12-17
DE60207389T2 (de) 2006-08-03
NO20033297D0 (no) 2003-07-22
EP1343542A2 (en) 2003-09-17
EP1368419A2 (en) 2003-12-10
AR032400A1 (es) 2003-11-05
CL2015003111A1 (es) 2016-07-08
EA006700B1 (ru) 2006-02-24
EE200300341A (et) 2003-10-15
AR032517A1 (es) 2003-11-12
WO2002058749A8 (en) 2004-03-11
EE200300349A (et) 2003-10-15
WO2002070594A3 (en) 2003-01-03
BRPI0206709B8 (pt) 2021-06-22
WO2002058749A3 (en) 2002-10-10
JP2004521115A (ja) 2004-07-15
HU228810B1 (hu) 2013-05-28
JP2004520124A (ja) 2004-07-08
IL157096A (en) 2007-08-19
JP4535678B2 (ja) 2010-09-01
KR20030086254A (ko) 2003-11-07
UA73028C2 (uk) 2005-05-16
HRP20030648A2 (en) 2005-06-30
WO2002058750A2 (en) 2002-08-01
BR0206709A (pt) 2004-02-17
EE200300348A (et) 2003-10-15
EE05685B1 (et) 2013-12-16
DK1368419T3 (da) 2006-04-03
UY27136A1 (es) 2002-09-30
WO2002058750A3 (en) 2002-10-31
BRPI0206709B1 (pt) 2015-09-08
PT1343542E (pt) 2005-08-31
EA200401463A1 (ru) 2005-08-25
BR0206708A (pt) 2004-02-25
CZ305120B6 (cs) 2015-05-13
SI1343542T1 (en) 2005-10-31
SK288120B6 (sk) 2013-09-03
SK10342003A3 (sk) 2004-02-03
IL157095A0 (en) 2004-02-08
EA200300822A1 (ru) 2004-02-26
EA006686B1 (ru) 2006-02-24
CN1507358A (zh) 2004-06-23
AU2002307809B2 (en) 2007-10-04
KR100847417B1 (ko) 2008-07-18
HUP0303893A3 (en) 2012-02-28
EP1547626A3 (en) 2009-07-29
RS50866B (sr) 2010-08-31
EP1343542B1 (en) 2005-03-23
WO2002070594A2 (en) 2002-09-12
HUP0303896A2 (hu) 2004-03-01
EA200300823A1 (ru) 2004-04-29
CZ20032199A3 (cs) 2003-12-17
HUP0400768A3 (en) 2006-01-30
HUP0400768A2 (hu) 2004-07-28
SK10352003A3 (sk) 2004-02-03
DK1343542T3 (da) 2005-07-25
IL157096A0 (en) 2004-02-08
AU2002249528B2 (en) 2007-03-29
NO20033296D0 (no) 2003-07-22
NO20033296L (no) 2003-09-25
BR0206705B1 (pt) 2012-08-07
EG24589A (en) 2009-12-01
ES2253523T3 (es) 2006-06-01
CA2435425C (en) 2010-07-27
EP1547626A2 (en) 2005-06-29
PL206197B1 (pl) 2010-07-30
SI1368419T1 (sl) 2006-06-30
CN1290907C (zh) 2006-12-20
HK1058319A1 (en) 2004-05-14
ATE291445T1 (de) 2005-04-15
KR20030085522A (ko) 2003-11-05
CA2434964A1 (en) 2002-08-01
CZ20032197A3 (cs) 2003-11-12
EP1359947A2 (en) 2003-11-12
YU67003A (sh) 2006-05-25
CN1487967A (zh) 2004-04-07
SK10362003A3 (sk) 2004-03-02
CZ304357B6 (cs) 2014-03-26
BG108121A (bg) 2004-08-31
BRPI0206708B1 (pt) 2015-07-14
CN1487843A (zh) 2004-04-07
NO20033295D0 (no) 2003-07-22
EG26417A (en) 2013-10-22
MXPA03006688A (es) 2004-03-12
EA005697B1 (ru) 2005-04-28
JP4104462B2 (ja) 2008-06-18
DE60207389D1 (de) 2005-12-22
CA2435159C (en) 2009-07-28
AU2002255220B2 (en) 2007-05-31
HK1058371A1 (en) 2004-05-14
CR7034A (es) 2004-03-05
HUP0303893A2 (hu) 2004-03-01
ME00587B (me) 2011-12-20
MXPA03006687A (es) 2004-03-12
BG108122A (bg) 2004-09-30
EE05587B1 (et) 2012-10-15
CA2435425A1 (en) 2002-08-01
MXPA03006689A (es) 2004-03-12
NO20033295L (no) 2003-09-25
KR100830294B1 (ko) 2008-05-16
WO2002070594A8 (en) 2004-03-11
PL206194B1 (pl) 2010-07-30
PL363274A1 (en) 2004-11-15
ME00587A (en) 2011-12-20
JP2007190399A (ja) 2007-08-02
PL205181B1 (pl) 2010-03-31
CA2435159A1 (en) 2002-09-12
DE60203364D1 (de) 2005-04-28
HRP20030648B1 (en) 2011-10-31
BR0206705A (pt) 2004-02-25
ATE310044T1 (de) 2005-12-15
BG66343B1 (bg) 2013-07-31
CA2434964C (en) 2009-04-21
BG66439B1 (bg) 2014-08-29
BG66420B1 (bg) 2014-03-31
NO20033297L (no) 2003-09-25
WO2002058749A2 (en) 2002-08-01
IL157097A0 (en) 2004-02-08
HUP0303896A3 (en) 2005-12-28

Similar Documents

Publication Publication Date Title
EE200300348A (et) Tahke koostis, mis koosneb peamiselt kollageenkandjast, tahkest fibrinogeenist ja tahkest trombiinist ning selle kasutamine
DE60212544D1 (de) Modifiziertes Propylenpolymer, davon erhältliche Klebstoffzusammensetzung und Klebstoff, der dieses umfasst
BR0215405A (pt) Composições e processos de uso de collajolie
PT1250343E (pt) Composicoes de antibioticos de azalida
FR2848115B1 (fr) Composition de bacteries et son utilisation
ID27922A (id) KOMPOSISI FARMASETIKAL DAN PENGGUNAAN DARI ANDROST-5-ENA-3β, 17β-DIOL
DE60121609D1 (de) Modifiziertes polyolefinharz, modifizierte polyolefinharzzusammensetzung und ihre verwendung
NO20005265L (no) Substituerte benzamider, deres fremstilling og anvendelse som inhibitorer av cystin-proteaser
AU2002366083A8 (en) Matrix for the production of tissue engineered ligaments, tendons and other tissue
AU2001276048A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001279284A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
IL169441A0 (en) Hemostatic compositions and uses therefor
ID30393A (id) Senyawa tienopirimidina, pembuatan dan penggunaannya
DE69932222D1 (de) Zementzusatzstoff, Zementzusammensetzung und polymere Polycarbonsäure
FI20021660L (fi) Hiilihydraattien uusi käyttö ja koostumukset
EP1289857A4 (en) MIXING OF MULTIPLE COMPONENTS
FI20022129A7 (fi) Rasvahappokoostumus, sen valmistus ja käyttö
EE05113B1 (et) Adhesiivssteem, k?vendi kompositsioon, nende kasutamine ja nende pealekandmismeetodid
EE04717B1 (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
ATE264108T1 (de) Endoparasitizide gelzusammensetzung
EE200100314A (et) Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine
ID26611A (id) Turunan-turunan pirol tersubstitusi heteroaril, pembuatannya dan kegunaan-kegunaan terapetiknya
EE200200167A (et) Sünteetiline nahk, meetod selle valmistamiseks ning kasutamine
AR028068A1 (es) Nuevos derivados de 1,1-dioxotiocromano y su uso como inhibidores de trombina
DE60115467D1 (de) Herstellungsverfahren und eigenschaften von styrol-butadien random-copolymer/poly(arylenether) zusammensetzungen

Legal Events

Date Code Title Description
HC1A Change of owner name